MedPath

Prospective evaluation of long-term effects after proton beam therapy on endocrine function of hypothalamus and pituitary gland in adults with brain and base of skull tumors

Recruiting
Conditions
endocrine function of hypothalamus and pituitary gland in brain and base of skull tumors
Registration Number
DRKS00014873
Lead Sponsor
Westdeutsches Protonentherapiezentrum Essen (WPE)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Age =18 years at the beginning of proton beam therapy
- Diagnosis of a brain tumor or a tumor at the base of the skull
- Proton beam therapy with justifying indication and consent to proton beam therapy
- Written informed consent to participation in WPE’s Adult Registry Study (ProReg)
- Written informed consent to the EndoPro study

Exclusion Criteria

- re-irradiation

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of radiation dose in proton beam therapy on endocrine function. Examination before the start of radiotherapy, 90 days after the end of treatment and further annually up to 5 years after the end of treatment.
Secondary Outcome Measures
NameTimeMethod
overall sirvival and progression-free survival
© Copyright 2025. All Rights Reserved by MedPath